Syncom Formulations Share Price Target From Tomorrow 2024 to 2030: An excellent player in the pharmaceutical manufacturing and distribution sector is the Indian pharmaceutical company Syncom Formulations. Founded with the goal of offering high-quality medications at lower costs, the company has steadily grown in popularity over time. With the pharmaceutical markets in India and throughout the world continuing to adjust, Syncom Formulations is well-positioned to take advantage of these developments and continue to grow. This analysis aims to give a comprehensive outlook on Syncom Formulations Share Price target from 2024 to 2030, taking into account the company’s current average performance, market conditions, financial history, and growth possibilities.
Syncom Formulations Share Price Current Market Details
- Open Price: ₹20.73
- High Price: ₹20.87
- Low Price: ₹19.41
- Market Capitalization: ₹1,830 Crores
- Price-to-Earnings (P/E) Ratio: 51.26
- Dividend Yield: Not Applicable
- 52-Week High: ₹23.05
- 52-Week Low: ₹7.25
- Current Price: ₹19.36 (+123.80% during the last one year)
Syncom Formulations Share Price Highlights
Syncom Formulations Share Price Target From Tomorrow 2024 to 2030: 2024 ₹28, 2025 ₹34, 2026 ₹40, 2027 ₹49, 2028 ₹55, 2029 ₹61, 2030 ₹67.
Syncom Formulations Share Price Target From Tomorrow 2024 to 2030
YEAR |
SHARE PRICE TARGET |
2024 |
₹28 |
2025 |
₹34 |
2026 |
₹40 |
2027 |
₹49 |
2028 |
₹55 |
2029 |
₹61 |
2030 |
₹67 |
Syncom Formulations Share Price Target From 2024:- ₹28
YEAR |
SHARE PRICE TARGET |
2024 |
₹28 |
Summary of SYNCOMF Share Price Forecast for 2024
- The initial price target for Syncom Formulations (India) Ltd in 2024 is projected to be ₹17.9.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹24.34.
- By the end of 2024, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹28.21, considering bullish market trends.
Syncom Formulations Share Price Target From 2025:- ₹34
YEAR |
SHARE PRICE TARGET |
2025 |
₹34 |
Summary of SYNCOMF Share Price Forecast for 2025
- The initial price target for Syncom Formulations (India) Ltd in 2025 is projected to be ₹29.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹28.
- By the end of 2025, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹34, considering bullish market trends.
Syncom Formulations Share Price Target From 2026:- ₹40
YEAR |
SHARE PRICE TARGET |
2026 |
₹40 |
Summary of SYNCOMF Share Price Forecast for 2026
- The initial price target for Syncom Formulations (India) Ltd in 2026 is projected to be ₹35.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹34.
- By the end of 2026, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹40, considering bullish market trends.
Syncom Formulations Share Price Target From 2027:- ₹49
YEAR |
SHARE PRICE TARGET |
2027 |
₹49 |
Summary of SYNCOMF Share Price Forecast for 2027
- The initial price target for Syncom Formulations (India) Ltd in 2027 is projected to be ₹41.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹40.
- By the end of 2027, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹49, considering bullish market trends.
Syncom Formulations Share Price Target From 2028:- ₹55
YEAR |
SHARE PRICE TARGET |
2028 |
₹55 |
Summary of SYNCOMF Share Price Forecast for 2028
- The initial price target for Syncom Formulations (India) Ltd in 2028 is projected to be ₹50.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹46.
- By the end of 2028, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹55, considering bullish market trends.
Syncom Formulations Share Price Target From 2029:- ₹61
YEAR |
SHARE PRICE TARGET |
2029 |
₹61 |
Summary of SYNCOMF Share Price Forecast for 2029
- The initial price target for Syncom Formulations (India) Ltd in 2029 is projected to be ₹56.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹52.
- By the end of 2029, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹61, considering bullish market trends.
Syncom Formulations Share Price Target From 2030:- ₹67
YEAR |
SHARE PRICE TARGET |
2030 |
₹67 |
Summary of SYNCOMF Share Price Forecast for 2030
- The initial price target for Syncom Formulations (India) Ltd in 2030 is projected to be ₹62.
- With favorable market conditions, the mid-year price target for Syncom Formulations (India) Ltd could reach ₹58.
- By the end of 2030, the price target for Syncom Formulations (India) Ltd is expected to potentially reach ₹67, considering bullish market trends.
Shareholding Pattern
- •Promoters: 50.57% (unchanged)
- Retail and Others: 49.34%
- Foreign Institutions (FII/FPI): 0.09% (stepped forward from 0.08%)
Key Takeaways from Forecasted Price for SYNCOMF from 2024 to 2030
- In 2024, Syncom Formulations (India) Ltd (SYNCOMF) is expected to experience strong growth, with an initial target of ₹17.9. However, market volatility might lead to fluctuations mid-year, peaking at ₹25.63.
- For Syncom Formulations (India) Ltd in 2025, a bullish trend might take the stock to a mid-year target of ₹29, followed by a steady climb to ₹34.
- In 2026, a temporary decline in early months for Syncom Formulations (India) Ltd is possible, with a recovery expected by mid-year, aiming for ₹35.
- Anticipating mixed trends for Syncom Formulations (India) Ltd in 2027, with rapid movements both upward and downward, yet maintaining an overall upward trajectory towards ₹49.
- For 2028 and 2029, Syncom Formulations (India) Ltd is expected to show strong and steady growth, potentially breaking past previous highs and setting new records.
- By 2030, the cumulative impact of market dynamics could lead Syncom Formulations (India) Ltd to a substantial year-end target, surpassing previous expectations.
MORE DETAIL OFFICIAL WEBSITE: https://syncomformulations.com/